{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-008129","form_type":"8-K","ticker":"PULM","cik":"0001574235","company_name":"Pulmatrix, Inc.","filed_at":"2026-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.503200+00:00","generated_at":"2026-05-15T23:35:58.397279+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Pulmatrix: $0 revenue in 2025, net loss $5.2M, plans to license iSPERSE","bullets":["Revenue $0 in 2025 vs $7.8M in 2024; net loss $5.2M ($1.41/share) vs $9.6M.","Cash and equivalents $4.1M at Dec 31, 2025, down from $9.5M; cash runway into Q1 2027.","Plans to license or monetize iSPERSE platform and migraine asset PUR3100.","Proposed merger with Cullgen pending CSRC approval; 'No Solicitation' clause waived to explore alternatives."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-008129","json":"https://secwatch.observer/filing/0001493152-26-008129.json","markdown":"https://secwatch.observer/filing/0001493152-26-008129.md","text":"https://secwatch.observer/filing/0001493152-26-008129.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1574235/000149315226008129/0001493152-26-008129-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1574235/000149315226008129/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T23:35:58.397279+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}